Yes, there is dire inequality in clinical trial enrollment, but this is the precisely wrong way to address the lack of diversity.

Legislating behavior leads to made-up plans that are at best a waste of an intern’s time and at worst a six-figure donation to “providers” selling their “solutions”. If you will ultimately grade on the outcome — and you should! — well, what do you care how it was achieved, provided that all the other laws and guidances were followed?

Silly, silly games.